EMDocs

MARCH 28, 2025

Heres another case from Medical Malpractice Insights – Learning from Lawsuits , a monthly email newsletter for ED physicians. The goal of MMI-LFL is to improve patient safety, educate physicians and reduce the cost and stress of medical malpractice lawsuits. To opt in to the free subscriber list, click here. Stories of med mal lawsuits can save lives.

Ultrasounds 75

Ultrasounds Patient Safety Hospitals Wellness 75

Sensible Medicine

MARCH 28, 2025

The career of the academic medicine doctor nicely breaks down into three parts. The first part, beginning right after training, is spent honing a craft and working to establish an academic niche: clinical excellence, research, education, or administration. In phase two, that early work pays off. The assistant or associate professor becomes a respected clinician, an educator developing or directing courses, a funded and published researcher, or an administrator with leadership roles within a depa

Academics 40

Academics Leadership Administration Research 40

St. Emlyn

MARCH 28, 2025

St.Emlyn's - Emergency Medicine #FOAMed From pragmatic frailty care to neurodiversity in medicine and creating safer cultures, Day 2 of RCEM 2025 blended sharp clinical insights with systems thinking. The post RCEM Conference 2025: Reflections from Day 2 appeared first on St.Emlyn's.

64

64

Life in the Fast Lane

MARCH 28, 2025

Kane Guthrie and Mike Cadogan LITFL Update 044 Update 044. Sending you FOAMed content from around the globe. Latest trends and best articles so thatyoustay top of your field.

52

52

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Outcomes

PulmCCM

MARCH 28, 2025

For patients in septic shock, norepinephrine has been recommended as the first vasopressor to be infused. Vasopressin is commonly added to norepinephrine, but controversy has reigned about whether and when to do so. Vasopressin has the apparent advantage of tending to reduce the required dose of norepinephrine, theoretically reducing toxicity from excess catecholamines.

Shock 40

Shock Sepsis Administration Outcomes 40